Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells
Sebastian Wimmer, Lisa Deloch, Michael Häder, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9114-9114
Open Access | Times Cited: 13

Showing 13 citing articles:

The Effect of Hyperthermia and Radiotherapy Sequence on Cancer Cell Death and the Immune Phenotype of Breast Cancer Cells
Azzaya Sengedorj, Michael Häder, Lukas Heger, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2050-2050
Open Access | Times Cited: 23
Tissue and circulating PD-L2: moving from health and immune-mediated diseases to head and neck oncology
Elena Muraro, Rebecca Romanò, Giuseppe Fanetti, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 175, pp. 103707-103707
Closed Access | Times Cited: 17
Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer – Results of a large multicenter analysis
Johannes Roesch, Michael Oertel, Simone Wegen, et al.
Radiotherapy and Oncology (2022) Vol. 181, pp. 109380-109380
Closed Access | Times Cited: 14
Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes
Annette Affolter, Kai Liebel, Luisa Tengler, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 3
Open Access | Times Cited: 7
To Die or Not to Die: Cell Death in Biology and Disease
Marcus Krüger, Peter Richter
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6734-6734
Open Access | Times Cited: 7
Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells
Eileen Stoll, Michael Häder, Michael Rückert, et al.
International Journal of Hyperthermia (2022) Vol. 39, Iss. 1, pp. 796-805
Open Access | Times Cited: 5
Active Immune Phenotype in Head and Neck Cancer: Reevaluating the Iso-Effect Fractionation Based on the Linear Quadratic (LQ) Model—A Narrative Review
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Current Oncology (2023) Vol. 30, Iss. 5, pp. 4805-4816
Open Access | Times Cited: 2
Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer – detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients’ peripheral blood
Anna-Jasmina Donaubauer, Benjamin Frey, Manuel Weber, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Identification of potential new T cell activation molecules: a Bioinformatic Approach
Mario Morales-Martínez, David Andón-García, Karla Aimee Patiño-Santiago, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Inhibition of ATM or ATR in combination with hypo-fractionated radiotherapy leads to a different immunophenotype on transcript and protein level in HNSCC
Julia Meidenbauer, M Wächter, Sebastian Schulz, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Clonogenicity-based radioresistance determines the expression of immune suppressive immune checkpoint molecules after hypofractionated irradiation of MDA-MB-231 triple-negative breast cancer cells
Simon Gehre, Felix Meyer, Azzaya Sengedorj, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells
Fridolin Grottker, Simon Gehre, Clara M. Reichardt, et al.
Neoplasia (2023) Vol. 45, pp. 100944-100944
Open Access | Times Cited: 1
Highlights der ASCO- und ESMO-Jahrestagungen 2021 zur Strahlentherapie von Kopf-Hals-Tumoren
Markus Hecht, Jens von der Grün, Sabine Semrau, et al.
HNO (2022) Vol. 70, Iss. 4, pp. 258-264
Closed Access | Times Cited: 1
Page 1

Scroll to top